Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors-Reference-Cited by-同舟云学术

Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors

Published:2016-02 Issue:2 Volume:22 Page:359-370
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Young Jo-Anne H.,Logan Brent R.,Wu Juan,Wingard John R.,Weisdorf Daniel J.,Mudrick Cathryn,Knust Kristin,Horowitz Mary M.,Confer Dennis L.,Dubberke Erik R.,Pergam Steven A.,Marty Francisco M.,Strasfeld Lynne M.,Brown Janice (Wes) M.,Langston Amelia A.,Schuster Mindy G.,Kaul Daniel R.,Martin Stanley I.,Anasetti Claudio

Funder

National Heart, Lung, and Blood Institute

National Cancer Institute

Office of Naval Research

National Marrow Donor Program

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference27 articles.

1. Peripheral-blood stem cells versus bone marrow from unrelated donors;Anasetti;N Engl J Med,2012

2. Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults-a systematic review and meta-analysis;Holtick;Crit Rev Oncol Hematol,2015

3. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults;Holtick;Cochrane Database Syst Rev,2014

4. Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies;Stamatovic;Vojnosanit Pregl,2011

5. Peripheral blood stem cells: a novel source for allogeneic transplantation;Korbling;Oncologist,1997

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft;Transplantation and Cellular Therapy;2024-02

2. Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy;Journal of Clinical Oncology;2024-01-10

3. High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T‐cell therapy for large B‐cell lymphoma;HemaSphere;2024-01

4. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients;The Lancet Infectious Diseases;2024-01

5. A single‐institution pre–post comparison of subcutaneous immunoglobulin replacement therapy in allogeneic haematopoietic cell transplantation recipients;British Journal of Haematology;2023-11-14